Cyber Swan Sale

50% Off Elite

Days

Hours

Mins

Sec

Get our most powerful screeners, new charting tools, and the fastest ad-free experience at our best price ever. One last chance.

NDRA

ENDRA Life Sciences Inc

Dec 02 • 04:00PM ET

5.99

+0.10 1.70 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: DXCM TTOO BFLY CDNA AXDX XGN MRSN BNBX CASI

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-13.39	Insider Own	22.55%	Shs Outstand	1.17M	Perf Week	26.37%
Market Cap	6.99M	Forward P/E	-	EPS next Y	-8.89	Insider Trans	0.00%	Shs Float	0.90M	Perf Month	14.10%
Enterprise Value	6.73M	PEG	-	EPS next Q	-1.95	Inst Own	1.12%	Short Float	11.14%	Perf Quarter	36.45%
Income	-8.01M	P/S	-	EPS this Y	86.86%	Inst Trans	3.42%	Short Ratio	0.35	Perf Half Y	72.13%
Sales	0.00M	P/B	27.50	EPS next Y	-18.85%	ROA	-154.83%	Short Interest	0.10M	Perf YTD	-4.31%
Book/sh	0.22	P/C	8.85	EPS next 5Y	-	ROE	-236.34%	52W High	11.96 -49.92%	Perf Year	-0.99%
Cash/sh	0.68	P/FCF	-	EPS past 3/5Y	81.97% 76.64%	ROIC	-1409.93%	52W Low	2.90 106.55%	Perf 3Y	-99.90%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	14.20% 14.89%	Perf 5Y	-99.98%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	98.86%	Oper. Margin	-	ATR (14)	0.77	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.31	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	52.30	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.31	EPS Q/Q	99.37%	SMA20	3.83%	Beta	-0.33	Target Price	38.00
Payout	-	Debt/Eq	3.12	Sales Q/Q	-	SMA50	3.42%	Rel Volume	0.04	Prev Close	5.89
Employees	21	LT Debt/Eq	2.35	Earnings	Nov 17 BMO	SMA200	25.30%	Avg Volume	283.36K	Price	5.99
IPO	Jun 30, 2017	Option/Short	No / Yes	EPS/Sales Surpr.	-7.69% -	Trades		Volume	12,296	Change	1.70%

Nov-20-25 08:00AM	ENDRA Feasibility Study Demonstrates TAEUS Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker (Business Wire) -15.19%
Nov-17-25 08:00AM	ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results (Business Wire) -7.46%
Nov-14-25 09:25AM	Endra Life Sciences commences staking of HYPE digital asset holdings (TipRanks)
Oct-23-25 08:00AM	ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings (Business Wire) -5.88%
Oct-16-25 08:57AM	Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition (Zacks) -5.53%
08:14AM	Loading…
Oct-13-25 08:14AM	Pulse Biosciences Unveils Promising First-in-Human Data for nPulse (Zacks) +25.31%
08:00AM	ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca (Business Wire)
Aug-14-25 04:05PM	ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results (Business Wire) +9.46%
Jun-16-25 08:00AM	ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard (Business Wire)
May-15-25 04:05PM	ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results (Business Wire)
Mar-31-25 08:05AM	ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies (Business Wire)
08:00AM	ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update (Business Wire)
Jan-28-25 12:00PM	What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock (Zacks)
Nov-22-24 08:00AM	ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement (Business Wire)
Nov-15-24 09:24AM	ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update (Business Wire) -14.18%
08:00AM	Loading…
Nov-12-24 08:00AM	Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting 2024 (Business Wire)
Nov-06-24 08:00AM	ENDRA Life Sciences Further Strengthens TAEUS Platform Intellectual Property with Issuance of 17th European Patent (Business Wire) -14.84%
Oct-22-24 08:00AM	ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany (Business Wire) +89.19%
Aug-28-24 04:17PM	ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements (Business Wire) -19.56%
Aug-22-24 04:14PM	ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update (Business Wire) -10.99%
Aug-16-24 08:00AM	ENDRA Life Sciences Announces Reverse Stock Split (Business Wire) -22.50%
Aug-13-24 04:05PM	ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024 (Business Wire)
08:00AM	ENDRA Life Sciences Announces Leadership Changes (Business Wire)
Aug-07-24 08:00AM	ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14 (Business Wire)
Jun-17-24 08:11AM	Why Is ENDRA Life Sciences (NDRA) Stock Up 36% Today? (InvestorPlace) +34.17%
07:40AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
Jun-05-24 07:35AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +63.41%
Jun-04-24 09:21AM	ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering (Business Wire) -60.83%
May-20-24 08:00AM	ENDRA Provides Update Following In-person Meeting with FDA (Business Wire)
May-15-24 03:10AM	ENDRA Life Sciences Inc (NDRA) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
04:05PM	Loading…
May-14-24 04:05PM	ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update (Business Wire)
May-07-24 08:00AM	ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024 (Business Wire) -6.41%
May-02-24 08:00AM	ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents (Business Wire) +15.48%
Apr-01-24 09:59AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.50%
Mar-29-24 06:21AM	Q4 2023 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 08:53PM	NDRA Stock Earnings: ENDRA Life Sciences Beats EPS for Q4 2023 (InvestorPlace) -29.29% -30.50%
04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (Business Wire)
Mar-21-24 08:00AM	ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024 (Business Wire) -8.76%
Feb-27-24 08:00AM	ENDRA Life Sciences Installs First TAEUS System in the UK (Business Wire)
Feb-21-24 08:00AM	New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences TAEUS System (Business Wire)
Feb-14-24 08:30AM	ENDRA Life Sciences Bolsters TAEUS System Intellectual Property with New Patents in U.S., China and Europe (Business Wire)
Nov-29-23 08:00AM	ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS System Technology (Business Wire)
Nov-27-23 08:00AM	ENDRA Life Sciences to Participate in The Benchmark Companys 12th Annual Discovery One-on-One Investor Conference (Business Wire)
Nov-15-23 01:23PM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-14-23 04:05PM	ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Nov-08-23 08:00AM	ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents (Business Wire)
Nov-07-23 04:05PM	ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023 (Business Wire)
Nov-06-23 08:00AM	ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLDs The Liver Meeting 2023 (Business Wire)
Sep-07-23 08:00AM	Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023 (Business Wire)
Aug-30-23 08:00AM	ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA (Business Wire) +6.31%
Aug-23-23 08:00AM	ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents (Business Wire)
Aug-20-23 11:20AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-15-23 06:49AM	Q2 2023 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents) -8.37%
Aug-14-23 04:05PM	ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update (Business Wire)
01:30PM	ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA (Business Wire)
Aug-01-23 08:00AM	ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023 (Business Wire)
Jul-12-23 05:15PM	Domino's Pizza teams up with Uber for food delivery partnership (Yahoo Finance Video)
03:27PM	Stocks to Watch Wednesday: Domino's, Coty, Activision, Lucid (The Wall Street Journal)
02:42PM	Analyst Report: Domino's Pizza, Inc. (Morningstar Research)
02:01PM	Domino's stock jumps on partnership with Uber Eats (Yahoo Finance)
12:31PM	Dominos Pizza Is Todays Hottest Stock (The Wall Street Journal)
10:30AM	Domino's Pizza stock jumps on delivery partnership with Uber (Yahoo Finance Video)
09:42AM	Dominos Pizza Is This Mornings Hottest Stock (The Wall Street Journal)
07:05AM	Domino's® Introduces a New Way to Order Using Uber Eats Marketplace (PR Newswire)
Jul-06-23 04:45PM	ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023 (Business Wire)
Jun-07-23 08:00AM	Study Highlighting ENDRA Life Sciences TAEUS Technology to be Presented at EASL International Liver Congress 2023 (Business Wire) +5.33%
May-15-23 04:05PM	ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update (Business Wire) -8.57%
May-04-23 08:00AM	ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023 (Business Wire) +8.70%
May-02-23 04:01PM	ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Securities (Business Wire) +17.24% -5.29%
Apr-28-23 08:00AM	ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering (Business Wire) +24.03%
Mar-17-23 05:00AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.00%
Mar-15-23 10:32AM	Q4 2022 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-23 04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire)
Mar-07-23 04:05PM	ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023 (Business Wire)
Dec-08-22 09:55AM	Here's Why ENDRA Life Sciences Inc. (NDRA) Could be Great Choice for a Bottom Fisher (Zacks) +6.79%
Dec-05-22 08:00AM	ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split (Business Wire) -12.10%
Nov-14-22 04:05PM	ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire) -10.22%
Nov-09-22 08:00AM	ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022 (Business Wire) -7.51%
Oct-25-22 08:00AM	ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents (Business Wire)
Oct-04-22 08:00AM	ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference (Business Wire)
Sep-29-22 04:05PM	ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks (Business Wire)
Sep-06-22 08:00AM	ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences (Business Wire)
Aug-24-22 08:40AM	ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System (Business Wire) +11.62%
Aug-15-22 04:30PM	Edited Transcript of NDRA.OQ earnings conference call or presentation 15-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents) -7.87%
04:05PM	ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-08-22 10:16AM	Here's Why ENDRA Life Sciences (NASDAQ:NDRA) Must Use Its Cash Wisely (Simply Wall St.)
Aug-04-22 08:00AM	ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 (Business Wire)
Aug-02-22 08:00AM	ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices (Business Wire)
Aug-01-22 08:00AM	ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference (Business Wire) +14.63%
Jul-11-22 08:00AM	ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS® System (Business Wire)
Jun-28-22 08:00AM	ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent (Business Wire) +7.11%
Jun-08-22 08:00AM	ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference (Business Wire) +6.97%
May-25-22 08:00AM	ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with Issuance of 27th U.S. Patent (Business Wire)
May-16-22 08:00AM	ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference (Business Wire)
May-12-22 04:05PM	ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire)
May-10-22 08:00AM	ENDRA Life Sciences Issued Additional U.S. and Chinese Patents for its TAEUS® System (Business Wire)
May-02-22 08:00AM	ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022 (Business Wire)
Apr-21-22 08:00AM	ENDRA Life Sciences Raises $8.7 Million in Gross Proceeds Through its At-The-Market Facility (Business Wire)
Mar-31-22 08:00AM	ENDRA Life Sciences Achieves Key Quality Management System Certification (Business Wire)
Mar-30-22 04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (Business Wire) +8.37%

ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Cyber Swan Sale

50% Off Elite

NDRA

ENDRA Life Sciences Inc

Upgrade your FINVIZ experience